Skip to content


  • Erratum
  • Open Access

Erratum to: A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids

  • 1Email author,
  • 2,
  • 3,
  • 4,
  • 5,
  • 2 and
  • 6
Respiratory Research201516:128

  • Received: 12 October 2015
  • Accepted: 12 October 2015
  • Published:

The original article was published in Respiratory Research 2015 16:20


Following publication of our article [1] we identified an error in Fig. 5, where results were inadvertently switched between morning and evening PEF responses. The corrected Fig. 5 is provided in this erratum. The PEF results provided in our original article text remain correct.
Fig. 5
Fig. 5

Morning and evening PEF response after 4 weeks of treatment (full analysis set). Adjusted for ‘treatment’, ‘period’, ‘patient’ and ‘baseline’. *p < 0.05 versus placebo Respimat®. PEF, peak expiratory flow



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

University Hospital Carl Gustav Carus, Technical University of Dresden, Fetscherstraße 74, 01307 Dresden, Germany
Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
Vilnius University Hospital, Vilnius, Lithuania
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany
Department of Pediatrics, Children’s Hospital of Colorado and the University of Colorado Denver School of Medicine, Aurora, Colorado, USA


  1. Vogelberg C, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M, Sigmund R, Hamelmann E, Engel M, et al. A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids. Respir Res. 2015;16:20.View ArticlePubMedPubMed CentralGoogle Scholar


© Vogelberg et al. 2015